+Search query
-Structure paper
Title | Azole-Based Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors. |
---|---|
Journal, issue, pages | J. Med. Chem., Vol. 64, Page 2205-2227, Year 2021 |
Publish date | Sep 24, 2020 (structure data deposition date) |
Authors | Rohrig, U.F. / Majjigapu, S.R. / Reynaud, A. / Pojer, F. / Dilek, N. / Reichenbach, P. / Ascencao, K. / Irving, M. / Coukos, G. / Vogel, P. ...Rohrig, U.F. / Majjigapu, S.R. / Reynaud, A. / Pojer, F. / Dilek, N. / Reichenbach, P. / Ascencao, K. / Irving, M. / Coukos, G. / Vogel, P. / Michielin, O. / Zoete, V. |
External links | J. Med. Chem. / PubMed:33557523 |
Methods | X-ray diffraction |
Resolution | 2.401 - 2.998 Å |
Structure data | PDB-7ah4: PDB-7ah5: PDB-7ah6: |
Chemicals | ChemComp-HEM: ChemComp-RCN: ChemComp-HOH: ChemComp-RCQ: ChemComp-RCW: ChemComp-GOL: |
Source |
|
Keywords | OXIDOREDUCTASE / Dioxygenase / Heme-containing enzyme / Structure-based drug design / IDO1 inhibitor / Triazole / Small-molecule inhibitor |